How has been the historical performance of Natural Biocon?

Answer:The historical performance of Natural Biocon shows a fluctuating trend in its financial metrics over the years.

Breakdown:
Natural Biocon's net sales have seen significant growth from Mar'20, where it reported no sales, to Mar'25 with sales of 8.35 Cr, although it decreased from 13.53 Cr in Mar'24. The total operating income followed a similar trend, rising from 0.00 Cr in Mar'20 to 8.35 Cr in Mar'25, but also down from 13.53 Cr the previous year. The total expenditure, excluding depreciation, increased from 0.03 Cr in Mar'20 to 8.29 Cr in Mar'25, reflecting the company's growing operational scale. Operating profit (PBDIT) was positive in Mar'25 at 0.06 Cr, down from 0.22 Cr in Mar'24, while profit before tax also decreased to 0.06 Cr in Mar'25 from 0.23 Cr in Mar'24. The profit after tax followed suit, dropping to 0.04 Cr in Mar'25 from 0.15 Cr in Mar'24. The earnings per share (EPS) also decreased to 0.02 in Mar'25 from 0.13 in Mar'24. On the balance sheet, total liabilities increased to 16.77 Cr in Mar'24 from 13.52 Cr in Mar'23, with total assets also rising to 16.77 Cr in Mar'24. However, the company has maintained no long-term borrowings throughout the years. The cash flow statements indicate no cash inflow or outflow across the years, suggesting a lack of operational cash generation. Overall, Natural Biocon's financial performance reflects a mix of growth and challenges in profitability and cash flow management.